Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China flag China · Delayed Price · Currency is CNY
8.00
+0.01 (0.13%)
Sep 16, 2026, 3:04 PM CST

Aier Eye Hospital Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
22,72422,28120,91020,31316,06914,973
Other Revenue
66.9971.5872.8354.341.1227.91
22,79122,35320,98320,36716,11015,001
Revenue Growth
3.86%6.53%3.02%26.43%7.39%25.93%
Cost of Revenue
12,34111,82310,88710,0227,9817,212
Gross Profit
10,45010,53010,09610,3458,1297,788
Selling, General & Admin
5,1275,3615,1434,6383,8513,406
Research & Development
265.51299.81317.98331.32269.9221.18
Other Operating Expenses
69.849.1863.3745.6544.6241.32
Operating Expenses
5,5635,8355,6415,1224,2433,766
Operating Income
4,8874,6954,4555,2233,8874,022
Interest Expense
-262.33-269.72-255.56-194.82-177.65-164.66
Interest & Investment Income
143.22147.31309.27165.73131.56199.53
Currency Exchange Gain (Loss)
-22.5171.3-10.3452.41128.9742.88
Other Non Operating Income (Expenses)
-13.73-68.94-40.24-54.19-38.19-44.93
EBT Excluding Unusual Items
4,7324,5754,4585,1923,9314,055
Impairment of Goodwill
-155.97-155.97-187.7-383.61-95.34-216.66
Gain (Loss) on Sale of Investments
43.1798.29334.4-79.42-356.89-448.39
Gain (Loss) on Sale of Assets
11.59.824.270.71-1.250.05
Asset Writedown
-8.43-8.2-6.82-6.11-5.01-4.27
Other Unusual Items
-264.08-93.55-8.24-172.76-137.88-237.77
Pretax Income
4,3584,4254,5944,5513,3353,148
Income Tax Expense
1,561951.92858.15895.02646.06677.85
Earnings From Continuing Operations
2,7973,4733,7363,6562,6892,470
Minority Interest in Earnings
-250.41-232.96-180.07-297.12-164.77-146.56
Net Income
2,5463,2403,5563,3592,5242,323
Net Income to Common
2,5463,2403,5563,3592,5242,323
Net Income Growth
-28.42%-8.88%5.87%33.06%8.65%34.78%
Shares Outstanding (Basic)
9,2829,2689,2449,2189,0479,054
Shares Outstanding (Diluted)
9,2829,2689,2449,2519,0609,054
Shares Change
0.27%0.27%-0.07%2.10%0.07%1.48%
EPS (Basic)
0.270.350.380.360.280.26
EPS (Diluted)
0.270.350.380.360.280.26
EPS Growth
-28.61%-9.12%5.95%30.33%8.57%32.82%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
3,6873,8803,0524,4123,1022,590
Free Cash Flow Per Share
0.400.420.330.480.340.29
Dividend Per Share
0.1000.1800.1600.1500.0770.071
Dividend Growth
-58.34%12.48%6.67%95.09%8.31%3.65%
Gross Margin
45.85%47.11%48.12%50.79%50.46%51.92%
Operating Margin
21.44%21.00%21.23%25.64%24.13%26.81%
Profit Margin
11.17%14.50%16.95%16.49%15.67%15.49%
Free Cash Flow Margin
16.18%17.36%14.54%21.66%19.26%17.27%
EBITDA
5,7745,5865,3015,9114,5074,511
EBITDA Margin
25.33%24.99%25.26%29.02%27.97%30.07%
D&A For EBITDA
886.4891.16845.92687.72619.79489.23
EBIT
4,8874,6954,4555,2233,8874,022
EBIT Margin
21.44%21.00%21.23%25.64%24.13%26.81%
Effective Tax Rate
35.83%21.51%18.68%19.67%19.37%21.53%
Revenue as Reported
22,79122,35320,98320,36716,11015,001
Advertising Expenses
-963.33987.95937.29723.56-